News
TSMRF
28.15
NaN%
--
Tsumura Lifts Year-End Dividend on Stronger Earnings and Signals Further Payout Hike
TipRanks · 2d ago
Tsumura Updates FY2026 Results and Consolidation of Chinese Herbal Medicine Subsidiary
TipRanks · 2d ago
Tsumura Grows Sales, Lifts Dividend Despite Profit Decline in FY2026
TipRanks · 2d ago
Tsumura Aligns Yomeishu Share Acquisition With Long-Term Kampo Healthcare Vision
TipRanks · 02/24 18:23
Tsumura to Take Yomeishu Private in ¥6.8 Billion Multi-Stage Deal to Expand Healthcare Portfolio
TipRanks · 02/24 18:23
Tsumura Updates Q3 FY2026 Results and Expands Consolidation of Chinese Herbal Subsidiary
TipRanks · 02/06 02:54
Tsumura Posts Higher Sales but Lower Profits, Keeps Full-Year Forecast and Dividend Plan Intact
TipRanks · 02/06 02:54
Tsumura Confirms It Is Weighing Reported Yomeishu Take-Private but Says No Decision Yet
TipRanks · 02/03 02:22
Tsumura Secures ¥50 Billion Syndicated Loan with Financial Covenants for Growth Investment
TipRanks · 01/16 02:52
Tsumura Completes Acquisition of Shanghai Hongqiao Stake
TipRanks · 11/10/2025 02:52
Tsumura & Co. Revises Medium-Term Plan with Higher Profit Targets
TipRanks · 11/10/2025 02:52
Tsumura & Co. Revises Earnings and Dividend Forecasts for FY 2026
TipRanks · 11/10/2025 02:52
Tsumura & Co. Reports Mixed Financial Results Amid Strategic Adjustments
TipRanks · 11/10/2025 02:52
Morgan Stanley Sticks to Their Hold Rating for Tsumura & Co (TSMRF)
TipRanks · 09/27/2025 09:55
Weekly Report: what happened at TSMRF last week (0908-0912)?
Weekly Report · 09/15/2025 10:51
Weekly Report: what happened at TSMRF last week (0901-0905)?
Weekly Report · 09/08/2025 10:53
Weekly Report: what happened at TSMRF last week (0825-0829)?
Weekly Report · 09/01/2025 10:49
Tsumura & Co. Enhances Stock Compensation System with Additional Funding
TipRanks · 08/27/2025 07:52
Tsumura & Co. Enhances Employee Stock Delivery System with Additional Funding
TipRanks · 08/26/2025 08:22
Weekly Report: what happened at TSMRF last week (0818-0822)?
Weekly Report · 08/25/2025 10:57
More
Webull provides a variety of real-time TSMRF stock news. You can receive the latest news about Tsumura & Co through multiple platforms. This information may help you make smarter investment decisions.
About TSMRF
Tsumura & Co is a Japan-based company mainly engaged in manufacturing and sales of prescription drugs and over-the-counter drugs. The Company operates the Pharmaceuticals segment. In Japan, the Company conducts the manufacturing, sales, transportation and storage of prescription drugs and over-the-counter drugs, and cultivation, procurement, selection, processing and storage of raw medicinal herbs. In China, the Company is engaged in regional management, business management, production and sales of herbal extract powders, cultivation, procurement, selection, processing and storage of herbal ingredients, and sales of pharmaceuticals and food products. In Laos, the Company is engaged in cultivation, procurement, selection, processing and storage of herbal ingredients. In the United States, the Company is engaged in pharmaceutical development business.